Protocol First: Source Upload facilitates trial continuity during COVID-19
The clinical trial technology empowers sites to monitor their operations remotely, saving time on tasks while increasing overall safety.
Archives for May 14, 2020
G1 Therapeutics: trilaciclib shows benefits for lung cancer patients
The company will present data from recent Phase 2 trials of the investigational drug at the upcoming ASCO20 virtual conference on May 29.
Gilead, Cipla partner on remdesivir expansion
The two companies will join forces on wider manufacturing and distribution of the investigational drug, granted an EUA to treat COVID-19 patients.
Nanoform granted GMP certification
The Finnish nanoparticle technology specialist’s facility has been given the stamp of approval by the Finnish Medicines Agency.